Jonathan Miller
About Jonathan Miller
Jonathan Miller serves as the Senior Director of Business Development and Finance at Leap Therapeutics, where he has worked since 2021. He holds an MBA from Georgetown University and a BS in Genetics from Cornell University, with prior experience in various roles at Ironwood Pharmaceuticals and Leap Therapeutics.
Current Role at Leap Therapeutics
Jonathan Miller serves as the Senior Director of Business Development & Finance at Leap Therapeutics, a position he has held since 2021. In this role, he is responsible for overseeing strategic initiatives that drive business growth and financial performance. His expertise in finance and business development is critical in shaping the company's strategic direction and operational efficiency.
Previous Experience at Leap Therapeutics
Prior to his current role, Jonathan Miller worked at Leap Therapeutics as the Associate Director of Business Development from 2018 to 2020. He also held the position of Director of Business Development & Finance for one year from 2020 to 2021. His tenure at Leap Therapeutics has involved significant contributions to the company's business strategy and financial planning.
Experience at Ironwood Pharmaceuticals
Jonathan Miller has a background in various roles at Ironwood Pharmaceuticals. He began as an intern in 2013 and later progressed to Manager of R&D / Strategy Finance from 2014 to 2015. He continued to advance within the company, serving as Manager of Corporate Development & Strategy Finance Business Partner from 2015 to 2016. His experience at Ironwood Pharmaceuticals provided him with a solid foundation in finance and strategic development.
Education and Expertise
Jonathan Miller earned his Master of Business Administration (MBA) from Georgetown University McDonough School of Business, where he studied from 2012 to 2014. He also holds a Bachelor of Science (BS) degree in Genetics from Cornell University, which he completed from 2004 to 2008. His educational background equips him with a strong analytical framework and understanding of both business and scientific principles.